Cargando…
Carbonic Anhydrase IX in Tumor Tissue and Plasma of Breast Cancer Patients: Reliable Biomarker of Hypoxia and Prognosis
Carbonic anhydrase IX (CA IX) is recognized as an excellent marker of hypoxia and an adverse prognostic factor in solid tumors, including breast cancer (BC). Clinical studies confirm that soluble CA IX (sCA IX), shed into body fluids, predicts the response to some therapeutics. However, CA IX is not...
Autores principales: | Rezuchova, Ingeborg, Bartosova, Maria, Belvoncikova, Petra, Takacova, Martina, Zatovicova, Miriam, Jelenska, Lenka, Csaderova, Lucia, Meciarova, Iveta, Pohlodek, Kamil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002431/ https://www.ncbi.nlm.nih.gov/pubmed/36901756 http://dx.doi.org/10.3390/ijms24054325 |
Ejemplares similares
-
ADAM10 mediates shedding of carbonic anhydrase IX ectodomain non-redundantly to ADAM17
por: Zatovicova, Miriam, et al.
Publicado: (2022) -
Carbonic Anhydrase IX—Mouse versus Human
por: Takacova, Martina, et al.
Publicado: (2019) -
Novel humanized monoclonal antibodies for targeting hypoxic human tumors via two distinct extracellular domains of carbonic anhydrase IX
por: Zatovicova, Miriam, et al.
Publicado: (2022) -
Hypoxia Marker Carbonic Anhydrase IX Is Present in Abdominal Aortic Aneurysm Tissue and Plasma
por: Grossmannova, Katarina, et al.
Publicado: (2022) -
Apoptosis-induced ectodomain shedding of hypoxia-regulated carbonic anhydrase IX from tumor cells: a double-edged response to chemotherapy
por: Vidlickova, Ivana, et al.
Publicado: (2016)